Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Chao

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
Anticancer Research|March 25, 2010
Phase II clinical trial of imatinib mesylate in therapy of KIT and/or PDGFRalpha-expressing Ewing sarcoma family of tumors and desmoplastic small round cell tumorsJoseph Chao, G Thomas Budd, Peiguo Chu, et al.
Annals of Surgical Oncology|August 31, 2020
Impact of Neoadjuvant Therapy on Minimally Invasive Surgical Outcomes in Advanced Gastric Cancer: An International Propensity Score-Matched StudyYongjia Yan, Annie Yang, Li Lu, et al.
Molecular Cancer|January 4, 2022
A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncologyIn-Seob Lee, Zhongxu Zhu, Jeeyun Lee, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2025
Vacuolar-ATPase inhibitors are antimicrobial agents active against intracellular mycobacteriaLeah Rankine-Wilson, Tirosh Shapira, Jake Felker, et al.
Translational Gastroenterology and Hepatology|June 25, 2019
Multimodality management of locally advanced gastric cancer-the timing and extent of surgeryCamille Stewart, Joseph Chao, Yi-Jen Chen, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|February 21, 2015
Dietary alterations and restrictions following surgery for upper gastrointestinal cancers: Key components of a health-related quality of life interventionVirginia Sun, Joseph Kim, Jae Y Kim, et al.
Journal of Pain and Symptom Management|May 13, 2018
Quality of Life, Symptoms, and Self-Management Strategies After Gastroesophageal Cancer SurgeryOliver S Eng, Jae Y Kim, Nora Ruel, et al.
Advances in Radiation Oncology|January 24, 2022
A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune ResponsesJoseph Chao, Ting-Fang He, Massimo D'Apuzzo, et al.
The Oncologist|June 26, 2025
Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinomaMichael S Lee, Joseph Chao, Mary F Mulcahy, et al.
Oncology|April 20, 2016
Phase Ib Trial of mFOLFOX6 and Everolimus (NSC-733504) in Patients with Metastatic Gastroesophageal AdenocarcinomaVincent Chung, Paul Frankel, Dean Lim, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Anticancer Research|March 25, 2010
Phase II clinical trial of imatinib mesylate in therapy of KIT and/or PDGFRalpha-expressing Ewing sarcoma family of tumors and desmoplastic small round cell tumorsJoseph Chao, G Thomas Budd, Peiguo Chu, et al.
Annals of Surgical Oncology|August 31, 2020
Impact of Neoadjuvant Therapy on Minimally Invasive Surgical Outcomes in Advanced Gastric Cancer: An International Propensity Score-Matched StudyYongjia Yan, Annie Yang, Li Lu, et al.
Molecular Cancer|January 4, 2022
A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncologyIn-Seob Lee, Zhongxu Zhu, Jeeyun Lee, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2025
Vacuolar-ATPase inhibitors are antimicrobial agents active against intracellular mycobacteriaLeah Rankine-Wilson, Tirosh Shapira, Jake Felker, et al.
Translational Gastroenterology and Hepatology|June 25, 2019
Multimodality management of locally advanced gastric cancer-the timing and extent of surgeryCamille Stewart, Joseph Chao, Yi-Jen Chen, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|February 21, 2015
Dietary alterations and restrictions following surgery for upper gastrointestinal cancers: Key components of a health-related quality of life interventionVirginia Sun, Joseph Kim, Jae Y Kim, et al.
Journal of Pain and Symptom Management|May 13, 2018
Quality of Life, Symptoms, and Self-Management Strategies After Gastroesophageal Cancer SurgeryOliver S Eng, Jae Y Kim, Nora Ruel, et al.
Advances in Radiation Oncology|January 24, 2022
A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune ResponsesJoseph Chao, Ting-Fang He, Massimo D'Apuzzo, et al.
The Oncologist|June 26, 2025
Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinomaMichael S Lee, Joseph Chao, Mary F Mulcahy, et al.
Oncology|April 20, 2016
Phase Ib Trial of mFOLFOX6 and Everolimus (NSC-733504) in Patients with Metastatic Gastroesophageal AdenocarcinomaVincent Chung, Paul Frankel, Dean Lim, et al.
Pageof 12